Delivery Order SPE2DB20D9135-SPE2DB22FD2ZP
Award Date 5/9/22
Potential Completion Date 5/10/22
Potential Value $7.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The $1,424.52 firm fixed-price delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the SPE2DB program administered by the Defense Logistics Agency (DLA), a defense agency. The $2,444.40 firm fixed-price contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA valued at up to $499,999,999, which allows the agency to issue delivery orders...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $4,074.00, is for the supply of NARCAN 4 MG NASAL SPRAY 2S to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical consumables to the Department of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a specialized pharmaceutical product, with a ceiling value of $7,780.80 and a period of performance through January 29, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the DLA's SPE2DB program. The contract is for the delivery of 4,554,970,111 units of NARCAN 4 mg Nasal Spray, a critical opioid overdose treatment medication, to support the recurring medical supply needs of military health facilities. The firm fixed-price contract, valued at $4,888.80, has an ultimate completion date of September 29, 2021. DMS...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides the Defense Logistics Agency (DLA) with delivery orders for NARCAN 4 MG NASAL SPRAY 2S medication. The contract, valued at $1,625.76, is a firm fixed-price delivery order with a completion date of June 16, 2022. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription...
- This federal contract award is for the delivery of 4556049371 units of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $16,296.00 and an ultimate completion date of January 26, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $7,333.20 contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- The U.S. Defense Logistics Agency awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,768,408 units of NARCAN 4 MG Nasal Spray. The $3,684 contract has a completion date of February 27, 2024. DMS Pharmaceutical Group is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger $4,999,999 Indefinite Delivery Vehicle (IDV) under DLA's SPE2DB program, which enables the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,518.40, is for the supply of NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...